Provisio Medical, Inc.: Funding, Investors & Team (Sep 2026)
By creating Sonic Lumen Tomography (SLTTM), a revolutionary intravascular ultrasound technique that gives precise and accurate real-time flow lumen dimensions, Provisio Medical hopes to transform endovascular operations. Additionally, the SLT platform may be simply incorporated into many of the endovascular devices that doctors now use. Provisio's SLT platform aims to effortlessly give doctors the information they need, when they need it, to improve clinical workflows and outcomes, without the drawbacks of low-resolution angiography's ionizing radiation and kidney-toxic contrast medium. Provisio's SLT technology is establishing a new paradigm in intravascular measures for evaluating clinical presentation, directing treatment choices including the appropriate sizing of therapeutic endovascular devices, and verifying the conclusion of treatment regimens.
Provisio Medical, Inc. has raised $12.6M across 2 funding rounds on record, the most recent an undisclosed round of $1.3M announced in May 2025.
That round is below the $1.7M median round size for Medical Equipment Manufacturing companies tracked on FundedIQ over the last two years.
Provisio Medical, Inc. Company Profile and Key Stats
Latest funding round on record: May 2025.
Provisio Medical, Inc. Funding Rounds
Provisio Medical, Inc. raised $11.3M in an undisclosed round announced in Nov 2022.
2.5 years later, an undisclosed round of $1.3M was announced in May 2025.
Provisio Medical, Inc. Founders and Leadership Team
No contact details are on record for this team yet.
Provisio Medical, Inc. Funding Compared to Other Medical Equipment Manufacturing Startups
Provisio Medical, Inc.'s latest round of $1.3M is below the median round in Medical Equipment Manufacturing. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Provisio Medical, Inc. in Medical Equipment Manufacturing and San Diego
Companies Similar to Provisio Medical, Inc.
Openwater is creating advanced imaging technologies that offer high resolution at a low cost. These…
UN&UP is an organization that helps people with unmet needs and those who are underprivileged.
Presidio Medical is a medtech company that develops a transformational neuromodulation platform. It enables…
Among patients with mitral valve regurgitation, NeoChord, a privately held medical technology business, is…
A startup medical device business in Silicon Valley called Embolx is creating microcatheters for artery…
Galen Robotics is creating a single-platform solution to assist surgeons in a variety of specialties with no…
ProFound Therapeutics is creating profound impacts on the understanding of biology and disease and the…
A multi-format private capital intelligence platform.
TRAXyL invented a new way to install broadband communications by essentially "painting" optical fiber…
Electric Pickle features pickleball courts, outdoor entertainment, and a restaurant with globally inspired…
Atorie is an online platform connecting luxury factories with customers that handles everything from…
Provisio Medical, Inc. Funding FAQs
What does Provisio Medical, Inc. do?
By creating Sonic Lumen Tomography (SLTTM), a revolutionary intravascular ultrasound technique that gives precise and accurate real-time flow lumen dimensions, Provisio Medical hopes to transform endovascular operations. Additionally, the SLT platform may be simply incorporated into many of the endovascular devices that doctors now use. Provisio's SLT platform aims to effortlessly give doctors the information they need, when they need it, to improve clinical workflows and outcomes, without the drawbacks of low-resolution angiography's ionizing radiation and kidney-toxic contrast medium. Provisio's SLT technology is establishing a new paradigm in intravascular measures for evaluating clinical presentation, directing treatment choices including the appropriate sizing of therapeutic endovascular devices, and verifying the conclusion of treatment regimens.
How much funding has Provisio Medical, Inc. raised?
Provisio Medical, Inc. has raised $12.6M across 2 rounds on record. The most recent is an undisclosed round of $1.3M announced in May 2025.
When did Provisio Medical, Inc. last raise funding?
Provisio Medical, Inc.'s most recent funding round on record is an undisclosed round of $1.3M, announced in May 2025.
Who founded Provisio Medical, Inc.?
FundedIQ lists S Eric Ryan (Founder) at Provisio Medical, Inc..
Who is the CEO of Provisio Medical, Inc.?
Eric Ryan is listed as CEO at Provisio Medical, Inc..
Where is Provisio Medical, Inc. headquartered?
Provisio Medical, Inc. is based in San Diego, California, United States.
How many employees does Provisio Medical, Inc. have?
Provisio Medical, Inc. is in the 11-50 employee band.
How does Provisio Medical, Inc.'s funding compare to other Medical Equipment Manufacturing startups?
Provisio Medical, Inc.'s latest round of $1.3M is below the $1.7M median round size for Medical Equipment Manufacturing companies on FundedIQ across 12 tracked companies over the last two years.
About FundedIQ's Provisio Medical, Inc. Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Provisio Medical, Inc. is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.